Managed Healthcare Executive February 1, 2024
New research finds that in 2022, U.S. prices across all drugs were almost three times higher than in other countries.
Beginning today, CMS begins the process of negotiating with the manufacturers of the first 10 drugs (list below) selected for negotiation under the Inflation Reduction Act (IRA) of 2022. CMS is sending proposals to manufacturers and plans to meet with companies up to three times during the spring and summer of 2024. New prices will take effect Jan. 1, 2026.
Department of Health and Human Services (HHS) Secretary Xavier Becerra said in a press release that he is confident that this process will lead to lower prices, although critics are concerned about the long-term impact of drug price negotiation on...
Today's Sponsors
Today's Sponsor